NEW YORK, NY / ACCESS Newswire / April 6, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading Officially Licensed Audiera Surpasses 1 Million Users — Ushering in a New Era of Glory.